Fortrea Holdings (FTRE) Accounts Payables (2022 - 2026)

Fortrea Holdings (FTRE) reported Accounts Payables of $70.8 million for Q1 2026, down 35.75% on a YoY basis from $110.2 million in Q1 2025, and up 138.38% quarter-over-quarter from $29.7 million in Q4 2025.

Fortrea Holdings (FTRE) Accounts Payables (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Accounts Payables for 5 years, with the latest figure at $70.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Accounts Payables fell 35.75% year-over-year to $70.8 million; the trailing twelve-month figure through Mar 2026 stood at $70.8 million (down 35.75% YoY), and the FY2025 full-year result was $29.7 million, down 78.51% from the prior year.
  • Accounts Payables for Q1 2026 stood at $70.8 million, up from $29.7 million in the prior quarter.
  • The five-year high for Accounts Payables was $144.2 million in Q2 2024, with the low at $29.7 million in Q4 2025.
  • Historically, Accounts Payables has averaged $104.0 million across 5 years, with a median of $110.2 million in 2025.
  • Annual changes were most pronounced in 2023 — Accounts Payables jumped 63.07% — and 2025, when it sank 78.51%.
  • Fortrea Holdings' Accounts Payables stood at $81.5 million in 2022, then jumped by 63.07% to $132.9 million in 2023, then rose by 3.99% to $138.2 million in 2024, then slumped by 78.51% to $29.7 million in 2025, then surged by 138.38% to $70.8 million in 2026.
  • The last three Accounts Payables figures came in at $70.8 million (Q1 2026), $29.7 million (Q4 2025), and $49.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.05 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 83.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 8.64 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 489.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 34.55 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 70.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 70.80 Mn
Dec 31, 2025 29.70 Mn
Sep 30, 2025 49.50 Mn
Jun 30, 2025 92.60 Mn
Mar 31, 2025 110.20 Mn
Dec 31, 2024 138.20 Mn
Sep 30, 2024 137.60 Mn
Jun 30, 2024 144.20 Mn
Mar 31, 2024 131.30 Mn
Dec 31, 2023 132.90 Mn
Sep 30, 2023 128.30 Mn
Jun 30, 2023 105.30 Mn
Dec 31, 2022 81.50 Mn